CCR8 | Chemokine (C-C motif) receptor 8 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CCR9 | Chemokine (C-C motif) receptor 9 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CCRL2 | Chemokine (C-C motif) receptor-like 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CD97 | CD97 molecule | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CELSR1 | Cadherin, EGF LAG seven-pass G-type receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
CELSR2 | Cadherin, EGF LAG seven-pass G-type receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CELSR3 | Cadherin, EGF LAG seven-pass G-type receptor 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CHRM1 | Cholinergic receptor, muscarinic 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CHRM2 | Cholinergic receptor, muscarinic 2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CHRM3 | Cholinergic receptor, muscarinic 3 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CHRM4 | Cholinergic receptor, muscarinic 4 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CHRM5 | Cholinergic receptor, muscarinic 5 | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CMKLR1 | Chemokine-like receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Expressed in all |
CNR1 | Cannabinoid receptor 1 (brain) | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CNR2 | Cannabinoid receptor 2 (macrophage) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CRHR1 | Corticotropin releasing hormone receptor 1 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
CRHR2 | Corticotropin releasing hormone receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CX3CR1 | Chemokine (C-X3-C motif) receptor 1 | Disease related genes G-protein coupled receptors Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR1 | Chemokine (C-X-C motif) receptor 1 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR3 | Chemokine (C-X-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR4 | Chemokine (C-X-C motif) receptor 4 | Cancer-related genes CD markers Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Expressed in all |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CXCR6 | Chemokine (C-X-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CYSLTR1 | Cysteinyl leukotriene receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Mixed |
CYSLTR2 | Cysteinyl leukotriene receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DRD1 | Dopamine receptor D1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
DRD2 | Dopamine receptor D2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DRD3 | Dopamine receptor D3 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
DRD4 | Dopamine receptor D4 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
EDNRA | Endothelin receptor type A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
EDNRB | Endothelin receptor type B | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
EMR1 | Egf-like module containing, mucin-like, hormone receptor-like 1 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
EMR2 | Egf-like module containing, mucin-like, hormone receptor-like 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
EMR3 | Egf-like module containing, mucin-like, hormone receptor-like 3 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
F2R | Coagulation factor II (thrombin) receptor | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
F2RL1 | Coagulation factor II (thrombin) receptor-like 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
F2RL2 | Coagulation factor II (thrombin) receptor-like 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
F2RL3 | Coagulation factor II (thrombin) receptor-like 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
FFAR1 | Free fatty acid receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR2 | Free fatty acid receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR3 | Free fatty acid receptor 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR4 | Free fatty acid receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
FPR1 | Formyl peptide receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FPR2 | Formyl peptide receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FPR3 | Formyl peptide receptor 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
FSHR | Follicle stimulating hormone receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
FZD1 | Frizzled class receptor 1 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |